← Back to Search

Dermal Filler

Hyaluronic Acid Fillers for Facial Volume Loss (RES Trial)

N/A

Waitlist Available

Led By Steven F Weiner, MD

Research Sponsored by Galderma R&D

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks, 6 months, 9 months, and 12 months after baseline

Awards & highlights

RES Trial Summary

This trial looked at how well two types of Hyaluronic Acid fillers show up on ultrasound imaging.

Who is the study for?

This trial is for individuals who can consent to participate, will follow the study's procedures, and have midface volume loss. It excludes those with previous permanent facial implants, recent facial treatments in the last 6 months that could affect results, or allergies to lidocaine and hyaluronic acid.Check my eligibility

What is being tested?

The study aims to compare how two different Hyaluronic Acid dermal fillers – Restylane Contour and Juvederm Voluma – accumulate in tissue when observed under ultrasound after being injected into participants' midfaces.See study design

What are the potential side effects?

While not explicitly listed here, common side effects of dermal fillers include swelling, redness at injection sites, bruising, pain or tenderness. Rarely they may cause allergic reactions or lumpiness.

RES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post-treatment, 4 weeks, 6 months, 9 months, and 12 months after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post-treatment, 4 weeks, 6 months, 9 months, and 12 months after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-treatment, 4 weeks, 6 months, 9 months, and 12 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assess and compare tissue aggregation and visualization of Hyaluronic Acid fillers using ultrasound

Secondary outcome measures

Evaluate subject satisfaction using self-assessment questionnaire

Evaluate volume change in the treated areas using 3D imaging

RES Trial Design

2Treatment groups

Active Control

Group I: Restylane ContourActive Control1 Intervention

Form: transparent gel of Hyaluronic Acid with the addition of lidocaine hydrochloride. Mode of administration: injection Dosage: at investigator's discretion for optimal outcome. Frequency and duration: injection at baseline and optional touch-up at week 4.

Group II: Juvederm VolumaActive Control1 Intervention

Form: sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, homogenous gel implant of Hyaluronic Acid crosslinked with BDDE, formulated with lidocaine. Mode of administration: injection Dosage: at investigator's discretion for optimal outcome. Frequency and duration: injection at baseline and optional touch-up at week 4.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Galderma R&DLead Sponsor

298 Previous Clinical Trials

60,319 Total Patients Enrolled

Steven F Weiner, MDPrincipal InvestigatorThe Aesthetic Clinique

Media Library

Juvederm Voluma (Dermal Filler) Clinical Trial Eligibility Overview. Trial Name: NCT05622851 — N/A

Midface Volume Deficiency Research Study Groups: Restylane Contour, Juvederm Voluma

Midface Volume Deficiency Clinical Trial 2023: Juvederm Voluma Highlights & Side Effects. Trial Name: NCT05622851 — N/A

Juvederm Voluma (Dermal Filler) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05622851 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this experiment commenced?

"Clinicaltrials.gov states that this experiment is not presently recruiting patients; the original posting was on July 12th 2022, with an update made most recently on November 11th 2022. Despite this trial being closed for recruitment currently, there are 1 other studies in progress looking to enroll participants."

Answered by AI

To what demographic is participation in this trial open?

"This experiment is currently recruiting 15 suitable candidates, aged 22 to 65, who have experienced a deficiency in their midface volume. To be eligible for the study, applicants must possess the capacity of giving consent and commit to adhering to all protocols as well as reporting back at predetermined times throughout the trial."

Answered by AI